Table 1 Patient characteristics
From: Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
Overall (N = 32) | |
|---|---|
Age | |
Mean (SD) | 64.6 (12.3) |
Sex | |
female | 6 (18.8%) |
male | 26 (81.3%) |
BMI | |
Mean (SD) | 24.2 (5.38) |
Smoker | |
current | 14 (43.8%) |
former | 11 (34.4%) |
never | 7 (21.9%) |
Tumor grade | |
1 | 3 (9.4%) |
2 | 19 (59.4%) |
3 | 9 (28.1%) |
missing | 1 (3.1%) |
Histology | |
adenocarcinoma | 15 (46.9%) |
SCC | 17 (53.1%) |
Intended Treatment (pre-PET) | |
definitive CRT | 15 (46.9%) |
neoadjuvant CRT | 16 (50.0%) |
other | 1 (3.1%) |
N-stage (pre-PET) | |
0 | 9 (28.1%) |
1 | 10 (31.3%) |
2 | 6 (18.8%) |
3 | 7 (21.9%) |
M-stage (pre-PET) | |
0 | 30 (93.8%) |
1* | 2 (6.3%) |